Amgen to pay $762 million, pleads guilty in marketing case

NEW YORK (Reuters) - Amgen Inc pleaded guilty in a New York federal court on Tuesday for improper marketing practices involving its once top-selling Aranesp anemia drug, and prosecutors said the company has agreed to pay $762 million in a civil se...

Source: http://health.yahoo.net/news/s/nm/amgen-to-pay-762-million-pleads-guilty-in-marketing-case

found here more for more more information